<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Thanos Kosmidis on Medium]]></title>
        <description><![CDATA[Stories by Thanos Kosmidis on Medium]]></description>
        <link>https://medium.com/@ThanosKosmidis?source=rss-89fa638e0e24------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*AQAXNpYZP_-WK0xN.jpg</url>
            <title>Stories by Thanos Kosmidis on Medium</title>
            <link>https://medium.com/@ThanosKosmidis?source=rss-89fa638e0e24------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Wed, 18 Nov 2026 08:08:05 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@ThanosKosmidis/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[2020 Healthcare trends]]></title>
            <link>https://medium.com/velocity-partners/2020-healthcare-trends-93c64ac4acb5?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/93c64ac4acb5</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Mon, 16 Mar 2020 10:16:24 GMT</pubDate>
            <atom:updated>2021-02-12T22:13:43.370Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-IL1ipSyb6kH2VivgjD1Kg.jpeg" /><figcaption>San Francisco, where JP Morgan holds its annual healthcare conference</figcaption></figure><p>The <a href="https://www.jpmorgan.com/global/healthcare-conference">JP Morgan Healthcare conference</a> is probably the most iconic one for the healthcare industry. Taking place in January in San Francisco, it is a 3–4 day conference traditionally focused on publicly traded companies, who get to share their plans (and respond to questions from industry leaders, the press, investors, fund managers, etc). More recently, the event has included private companies which JP Morgan believes are interesting enough (or close enough to an IPO) to present. Similarly, companies which are not entirely focused on healthcare have started to get invited (e.g. NVIDIA).</p><p>Another reason for making this a unique conference is that attendance is by invitation only.</p><p>So, how come this conference with less than 10,000 attendees attracts many more people to San Francisco in early January? This is also partly due to the dozens of satellite events taking place throughout the week; but more on those later.</p><h3>JPM 2020: Highlights</h3><p>While this year’s conference did not include a mega-merger (like JPM2019 featuring the merger of Bristol-Myers Squibb and Celgene), they were not entirely missing.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*PIsEkZxjuYqjXHvmiO8XJw.jpeg" /><figcaption>The first appearance of Bristol Myers-Squibb &amp; Celgene as one company in January 2019, standing-room-only</figcaption></figure><p>More specifically, <a href="http://www.teladoc.com/">Teladoc Health</a> (a leading <strong>telemedicine</strong> company) announced its acquisition of <a href="http://www.intouchhealth.com/">InTouch Health</a> (a provider of telehealth solutions). This was probably driven by the natural evolution towards integration, and aims to position Teladoc as an integrated service provider — but also help differentiate itself from its competition. The acquisition will cost $600M, while InTouch Health had $80M in revenue in 2019 (up 35% compared to 2018).</p><p>Beyond this, and shifting the focus to <strong>pharmaceutical and biotech</strong> companies, their R&amp;D pipelines remained the central theme, with cancer taking the lion’s share in most cases. The relative abundance of funding and the many unmet needs has led to increasing numbers of biotech companies with up to a handful of drug candidates; still, the fundamental economics, processes and value chain have not changed dramatically. However, the pressure on access and prices is increasing, especially given the macroeconomics, and particularly in the US.</p><p>When it comes to <strong>delivering</strong> care and drugs to patients, the race is on. <a href="http://www.cvs.com/">CVS</a> (the large <strong>pharmacy</strong> chain) for example, which had merged with <a href="http://www.aetna.com/">Aetna</a> (the insurance company), announced that they offer cheap medications to Aetna members, leveraging the scope of their integration. Moreover, they aim to have 1500 “HealthHubs” by the end of 2021, where healthcare professionals will serve customers, akin to a clinic. All this, while the direct competition with Amazon’s <a href="http://www.pillpack.com/">Pillpack</a> (acquired for $750m in mid-2018) is now peppered with at least one<a href="https://www.businessinsider.com/cvs-pillpack-lawsuit-reveals-amazon-plans-to-sell-employers-prescriptions-2019-6"> lawsuit</a>.</p><p><strong>JPM and Digital Health</strong></p><p>When the US government’s administrator for Medicare and Medicaid highlights the importance of <strong>digital health and technological innovation</strong>, it is a sign of maturity. However, this sparked a broad debate about definitions, applicability, evidence, uptake, and hype of digital health — making some wonder whether it is mature enough for prime time. The big picture, however, shows that the direction is following the lead of companies like Google, Novartis, Salesforce, Roche, Kaiser Permanente, and countless others. There are plenty of elements missing or not entirely there, though: evidence, patient engagement, clarity of privacy and security, and integration with the “back end” of healthcare.</p><p>Many attendees, however, tried to see the big picture; while acknowledging that it is a driving force for positive change and transformation, their view was that digital health, e-health, m-health, and the like, should just be considered part of Health and Healthcare. Some blamed technologists from trying to force their innovations into healthcare, while others accused the incumbents of slowing down progress.</p><p>In this time of transition, though, they all seemed to agree that <strong>entrepreneurs should focus on impact that is sustainable and measurable, and not on the technology that brings it</strong>.</p><p><strong>Satellite events</strong></p><p>The city of San Francisco, already bustling with entrepreneurial spirit, becomes a hive for exciting and interesting events, day conferences, or series of thematic forums. Here are some:</p><p>● <em>China Focus: the latest innovations and investment opportunities from China, by China, or for China</em>. The number and size of Chinese biopharma companies is impressive; given the access to cheaper resources, their R&amp;D activities move relatively fast (also aided by the local regulators’ approach) and in some cases they have strong results. However, concerns and challenges around intellectual property and other important aspects remain.</p><p>● <em>BCG events on Digital &amp; Analytics and Value Creation.</em> The patient in healthcare is still under-represented, but patient analytics and data are becoming the central piece of an increasing number of strategies and business models. This is where patient engagement shines through multiple touchpoints. Regarding Value Creation, technology is playing a critical role; from medical devices to wearables to Artificial Intelligence, enhancements can touch patients, clinicians, manufacturers and regulators.</p><p>● <em>McDermott &amp; EY:</em> Digital Health Pioneers Forum &amp; Life Sciences Investment Forum: It is no wonder that professional services firms are focusing so much on Digital Health and investments. Clearly, privacy is a fundamental element when it comes to Digital Health adoption. Moreover, in a time of abundance of funding opportunities (but limited time), complexities in planning &amp; execution seem to be important showstoppers.</p><p>Other events of note include:</p><p>● Startup Health<br>● Israel’s Next Gen Health gathering<br>● UC Davis’ Biotech innovation showcase<br>● Button’s showcase night<br>● WuXi NextCode’s half-day conference<br>● GenScript Biotech conference.</p><p><strong>What does this mean for you?</strong></p><p>If you are in the healthcare space, it is important to have the JPM conference and its satellite events on your radar, at the very least. This is where interests get aligned, policies are being crafted, and partnerships begin to take shape.</p><p>Perhaps most importantly, though, it is critical to keep in mind that healthcare is essentially an ecosystem of verticals, and an industry with enormous complexity. Events like those taking place in San Francisco in early January are a great showcase for this, but you still need to keep your eye on the ball in order to have an impact.</p><p>Of course, if you are an early stage startup company that has recently entered the field, it is important to keep things in perspective and remember that pockets of innovation and untapped opportunities exist almost everywhere in healthcare, and well beyond the headlines and events. Making a difference by employing the right technology, go-to-market approach and business model is a big challenge — but can be an extremely rewarding one.</p><p><em>About Thanos Kosmidis</em></p><p><a href="https://www.linkedin.com/in/tkosmidis">Thanos</a> is a health technology entrepreneur with 20 years of experience in the US and Europe, and is the cofounder &amp; CEO of CareAcross, a digital health company focusing on cancer. Thanos serves as an advisor to Velocity.Partners, an early stage venture capital fund, assisting in identifying, evaluating and supporting companies that strive for impact.</p><p><em>About Velocity.Partners</em></p><p><a href="https://velocitypartners.vc/">Velocity.Partners</a> is an industry agnostic Venture Capital fund. Our mission is to fuel Greek entrepreneurs around the globe build world-class technology companies.</p><p>We invest in pre-Seed &amp; Seed stages, typically up to €500K, and follow up next rounds, helping our companies build their team, prove product-market fit, gain market traction and get ready for big-league VCs along the way.</p><p>Our portfolio gets instant access to a global network of industry experts, international investors and potential clients. We also offer lifelong operational support, strategic advice and mentoring as needed.</p><p>Velocity.Partners is part of the Equifund family of venture capital funds and is also supported by the Operational Program “Competitiveness, Entrepreneurship &amp; Innovation” (EPAnEK).</p><p><em>To join the Velocity.Partners family of startups, do not hesitate to send us your pitch deck at </em><a href="/service/mailto:start@velocitypartners.vc"><em>start@velocitypartners.vc</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=93c64ac4acb5" width="1" height="1" alt=""><hr><p><a href="https://medium.com/velocity-partners/2020-healthcare-trends-93c64ac4acb5">2020 Healthcare trends</a> was originally published in <a href="https://medium.com/velocity-partners">Velocity.Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Digital Health, Health 2.0, or Health Tech? Does it matter?]]></title>
            <link>https://medium.com/velocity-partners/digital-health-health-2-0-or-health-tech-does-it-matter-b82aa136d572?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/b82aa136d572</guid>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[fundraising]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[ehealth]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Fri, 31 Aug 2018 07:09:38 GMT</pubDate>
            <atom:updated>2018-08-31T08:47:30.821Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/450/1*gj_5-pVoij9Sum28SJcdsQ.png" /></figure><p>Over the past few years, an increasing focus is placed in the area of healthcare, as a field ripe for innovation. A number of reasons are behind this growing interest, including:</p><ul><li>Increasing costs to the healthcare system (public but also private) are placing an unsustainable burden on governments and companies</li><li>Personal health costs, as applicable (e.g. over the counter medications, diagnostics, supportive treatments) are growing out of proportion</li><li>A rapidly aging population on a global scale</li><li>Large number of diseases with increasing incidence rate</li><li>Conditions which, thanks to scientific and overall progress, become long-term or chronic, affecting millions of people indefinitely</li><li>Exponentially growing impact of disease and absenteeism to productivity</li><li>Co-morbidities and polypharmacy imposing their severe and combined burden on quality of life</li><li>Escalating costs of pre-clinical and clinical research for new medications, with decreasing success rates.</li></ul><p>While the above are placing the world’s collective health on a negative spiral, there are plenty of positive developments that cannot be ignored, like:</p><ul><li>The ever-growing sophistication of processes required across all parts of healthcare</li><li>The unprecedented rate of increase in health-related data being produced (by individuals but not only)</li><li>Advances in the fields of genomics and genetics, that augment the scope of their impact but also increase the unknowns</li><li>Democratization of innovation, whereby enhancements can be implemented rapidly, with shrinking costs</li><li>The emergence (or second coming?) of technologies and capabilities orthogonal to healthcare, like artificial intelligence, virtual and augmented reality, big data, blockchain, and more</li><li>Constant evolution of business models, in a previously monolithic and rigid ecosystem of payers, providers and citizens.</li></ul><p>Clearly, technology has a central role to play in how we strive to lead a healthy life, prevent, diagnose and treat disease, as well as how the healthcare stakeholders collaborate, compete, make money and save costs. And the driving force behind these technological changes includes the multitude of current and future startups striving to make a difference.</p><p><strong>What’s in a name?</strong></p><p>As more people focus on healthcare innovation, the space itself expands and begins to adopt many different names.</p><p><em>“e-Health”</em> was probably one the first such names given to the intersection of health and technology. Soon enough, the realization that most of the healthcare touchpoints (but not the essence of health yet) are technologically driven or enabled, led to the gradual abolition of this name.</p><p><em>“m-Health”</em> emerged as the nearest hint to the ever-present role mobile phones and devices are playing in our lives. As a term, its significance was watered down given the prevalence of these technologies: since anything mobile was getting connected, why distinguish them?</p><p><em>“Health 2.0”</em> is perhaps the most natural parallel drawn with the rest of the technology world: after all, the Web 2.0 concept grew so much that it evolved to encompass anything connected to “the internet”.</p><p><em>“Digital Health”</em> is a clear indication of the inevitable: even health, the last frontier of old paradigms (including paper forms, lack of interoperability, and data silos), is slowly but surely giving in to the digital ways and infrastructure.</p><p><em>“Health Tech”</em> aims to adopt the naming convention of so many other technologies (like FinTech, PropTech, AgriTech, and more). Its initial scope of describing the technology itself has been enlarged to include the new health paradigms that emerge.</p><p><em>“Med Tech”</em> often describes medical devices and/or wearables, which may be used throughout the path of care but also beyond it. Given the growing scope of “medical devices” (which, sometimes, are not actual devices).</p><p><strong>Healthcare system geography</strong></p><p>Technology unites the world: someone in a remote island in Greece may be able to use the same fundamental technologies with a teenager in a village in central Africa and a senior citizen in Helsinki. In a disturbing reversal, this is not the same in health: access to healthcare services and medications, regulatory frameworks, pricing models, and more… these are wildly unstructured and fragmented.</p><p>This is why many health startups are focusing on specific regions or countries — often accepting the fact that their growth beyond these borders may require a completely new approach.</p><p>At the same time, this is one of the reason that the application of technology to healthcare can be so exciting: the dynamics of our daily interaction are such that require a strictly multi-dimensional approach: no single size fits all, and no approach is panacea.</p><p>If someone cannot recognize this in the healthcare field, they are in for a surprise.</p><p><strong>Technology as an enabler</strong></p><p>How many times have you heard the word “disruption” lately? Doesn’t it make you feel liberated, with enormous potential and unlimited applications?</p><p>Now…how would you feel if you were told that your health is about to be disrupted?</p><p>It is absolutely critical for health entrepreneurs to recognize the value and role of technology, in the context of the citizens, patients, caregivers, healthcare professionals, healthcare providers and organizations, private and public insurance payers, etc.</p><p>At the same time, it is important to acknowledge that the introduction of technology should not be done for technology’s sake. On the contrary, there are still a few young companies which suffer from the fallacy of “solutions looking for problems”.</p><p><strong>The current status: change is everywhere. Be a part of it!</strong></p><p>There is growing interest in applying high-tech to healthcare. Even the most “traditional” players (for example, insurance companies, hospitals and care homes, to name only a few) are beginning to see the important gaps and opportunities.</p><p>2018 midyear global funding report from <a href="https://www.slideshare.net/StartUpHealth/2018-startup-health-insights-global-digital-health-funding-report-2018-midyear">Startup Health</a> and <a href="https://rockhealth.com/reports/2018-midyear-funding-review-digital-health-deja-vu-in-yet-another-record-breaking-half/">RockHealth</a></p><p><a href="https://www.mobihealthnews.com/content/44-digital-health-mergers-acquisitions-2017">The 2017 M&amp;A report in Digital Health (MobiHealthNews)</a></p><p><a href="https://www.cnbc.com/2018/02/15/roche-buying-flatiron-health-backed-by-alphabet.html">The largest acquisition to date: Roche buys Flatiron valued at $2.1B</a></p><p><a href="https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/digital-therapeutics-preparing-for-takeoff">Digital Therapeutics: McKinsey’s view</a></p><p><strong>Eager to make a difference in healthcare?</strong></p><p>Enter <a href="http://velocitypartners.vc/">Velocity.Partners</a> — the pre-seed/seed Venture Capital Fund supercharging exceptional founders.</p><p>If you are you working on the intersection of technology and health, we want to hear from you! <a href="/service/mailto:start@velocitypartners.vc">Email us</a> with some information about what drives you to make a difference, and your slidedeck, and we will get back to you soon!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b82aa136d572" width="1" height="1" alt=""><hr><p><a href="https://medium.com/velocity-partners/digital-health-health-2-0-or-health-tech-does-it-matter-b82aa136d572">Digital Health, Health 2.0, or Health Tech? Does it matter?</a> was originally published in <a href="https://medium.com/velocity-partners">Velocity.Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Oncology 2.0]]></title>
            <link>https://medium.com/@ThanosKosmidis/oncology-2-0-c14624efb933?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/c14624efb933</guid>
            <category><![CDATA[joe-biden]]></category>
            <category><![CDATA[cancer-moonshot]]></category>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[healthcare-it]]></category>
            <category><![CDATA[digital-health]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Tue, 21 Jun 2016 10:59:10 GMT</pubDate>
            <atom:updated>2016-06-21T10:59:10.773Z</atom:updated>
            <content:encoded><![CDATA[<h3>Oncology 2.0: The view from ASCO 2016</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*2IDkLyfFR6P-JZrsvJlgfA.png" /><figcaption>©2016 American Society of Clinical Oncology (ASCO) All Rights Reserved Worldwide</figcaption></figure><p>It is not very often that the Vice President of the United States attends a top scientific conference.</p><p>It is even rarer to see the VP at a medical conference on cancer.</p><p>But lately, Joe Biden has not only been attending oncology conferences — he has been also delivering speeches there. Speeches where, instead of the political language expected from a VP, one hears about <strong>genomic data, clinical trials, personalized medicine, big data and more.</strong></p><p>These, among others, were the topics Mr Biden brought up in his 30-minute speech to a packed audience of oncologists and healthcare executives at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago earlier this June.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/480/1*9tJeRhaZOTkEKPM9q4f7ow.jpeg" /><figcaption>© Jim Young/Reuters, via <a href="http://www.businessinsider.com/joe-biden-cancer-moonshot-asco-talk-2016-6">BusinessInsider</a></figcaption></figure><p>As the appointed leader of the “Cancer Moonshot” program, <strong>Mr Biden has been the loudest voice for more research, more trials, more data, more collaboration… and for less cancer</strong>.</p><p>He is not alone. The millions affected by cancer worldwide today, and the millions that will be diagnosed in the next 365 days, want more. The hundreds of thousands of doctors, nurses, researchers, officers, want more.</p><p>And this has not changed even before Nixon declared “war on cancer” in 1971. But something is beginning to change outside the hospital walls, beyond the chemo wards, away from the radiotherapy basements.</p><p><strong>It is changing in storage servers planted in cold rooms across the globe; in smartphones in the hands of millions, in algorithms built to forget and re-learn, in pattern recognition, in patient engagement.</strong></p><h3><strong>New tools for doctors, patients, researchers</strong></h3><p>Here are some of the newest developments around cancer, to facilitate diagnosis, treatment and long-term patient care.</p><p><strong>Liquid biopsies: </strong>Traditionally, biopsies are taken by analyzing tissue from the tumor itself. This means that doctors must (a) have determined that a tumor indeed exists (b) know exactly where it is located (c) have access to that location in the body, to extract some tissue using procedure like fine-needle aspiration biopsy. With liquid biopsies, the presence of some tumors can be determined by analyzing a blood sample. Dozens of startups (and more established companies) have emerged recently to build technologies for this procedure, and conquer a broader market estimated to be worth between <a href="http://www.nanalyze.com/2016/01/8-companies-developing-liquid-biopsy-cancer-tests/">$10B</a>-<a href="http://www.bloomberg.com/news/articles/2016-04-06/cancer-blood-test-is-either-200-billion-market-or-a-pipe-dream">$200B</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*f-ZYlRwhoQz-0CHxl-53-w.jpeg" /></figure><p><strong>Genomics</strong>: The foundation of personalized, stratified, or precision medicine is the analysis of individual genomes to find specific patterns or mutations. With numerous drugs under development for each of these, the promise remains that going after the “root” of the tumor (a genetic mutation) will be more effective than attacking all cells, or a specific area in the body. In parallel with the genomics field, companion diagnostics constitute a large and growing industry with <a href="http://www.pmlive.com/pharma_news/astrazeneca_to_develop_lynparza_companion_diagnostic_1034993">interesting potential</a>.</p><p><strong>Genomic databases</strong>: Genetic discoveries are based on analysis of large amounts of data. This data is, for the most part, waiting to be extracted from our own bodies — and then combined in data marts. As with any data analysis, volume is a key determinant of success, hence the need to aggregate a lot of genomic data. Efforts like the <a href="http://www.genomicsengland.co.uk/the-100000-genomes-project/">100,000 Genomes Project</a> (UK) and the recently announced <a href="https://gdc.nci.nih.gov/">Genomic Data Commons</a> (USA) can help drive this forward.</p><p><strong>Collaboration platforms</strong>: Healthcare has collaboration built-in: the human body is too complicated to be left to any single individual. In oncology, in particular, Multi-Disciplinary Teams may include medical oncologists, radiation oncologists, surgeons, nurses, and others. These teams are gradually being expanded, to include dietitians, psychologists, palliative care specialists and more. In some cases, these teams convene virtually, and often asynchronously, over online platforms that allow them to collaborate more effectively, with visual aids and data access as necessary. As these platforms mature further, the broader team may begin to include the patient and/or the caregiver — leading to participatory medicine in practice.</p><h3><strong>ASCO 2016: relevant abstracts</strong></h3><p>The <a href="http://am.asco.org/">ASCO annual meeting</a> is the largest gathering of oncologists worldwide — with more than 35,000 professionals in each of the recent years. It is where breakthrough results from clinical trials are announced; where hundreds of scientific abstracts and posters are discussed; where dozens of educational sessions are hosted for junior doctors and not only.</p><p>In a field where evidence is an absolute requirement for practice-changing news, the ASCO congress is certainly a lagging indicator for technological trends. One will not witness the marvels of technology as fast as in other sectors, but this is where they are needed the most.</p><p>But technology is moving… from the back of the bus to the front. The change is happening, and it is being accelerated at the intersection of disciplines: <strong>computational biology, artificial intelligence, big data analytics, wearables, mobile apps, image recognition, telemedicine </strong>… The list goes on.</p><p>It is worth getting a glimpse of how these disciplines are affecting cancer diagnosis and treatment, but most importantly patient care. Below are a few relevant abstracts presented or published in conjunction with the 2016 annual meeting.</p><ul><li><em>Electronic tool to manage chemotherapy side-effects</em></li></ul><p>Self-care represents a growing need for cancer patients, no matter their health status or access to care. Scientists from Toronto recognized the many gaps in the current approach to managing side-effects from chemotherapy (or any other cancer treatment for that matter), and worked with patients and healthcare professionals to deliver an electronic tool. In particular, they co-designed with patients a tablet application that adds self-management advice and support from healthcare professionals to the “routine” care levels.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*iRLqMIcOCbi6xZRb-BRfAw.jpeg" /><figcaption>(c) Creative Commons by <a href="https://en.wikipedia.org/wiki/File:Drug_Evaluation_Process.jpg">Wikipedia</a></figcaption></figure><ul><li><em>Optimizing clinical trial design with new tools</em></li></ul><p>Designing a clinical trial is one of the most complicated parts of moving a promising treatment closer to the market. One of the most challenging aspects is to identify the right dose for a phase I clinical trial. A biostatistician delivered a crowd-sourced tool to help investigators construct, compare and calibrate multiple designs online. As per the description of the <a href="http://www.compgenome.org/NGDF/">tool</a>, it assumes that a fixed number of doses is predetermined and allows users to evaluate three designs by running computer simulations.</p><ul><li><em>Decision-support tool for doctors</em></li></ul><p>Doctors are faced with many decisions — the most important of which can really affect patient care. A knowledge-based system, based on a client-server architecture, was designed to offer interactive assistance for diagnosing and treating chronic myeloid leukemia (CML) and some bone marrow syndromes. As the author of the abstract (a medical doctor) states, the system uses approaches from artificial intelligence, such as the Bayesian inference or machine learning methods — applied to the modulated, established medical guidelines with reference to the individual patient information.</p><ul><li><em>An online expert system for breast cancer</em></li></ul><p>Access to oncology experts is far from perfect, and providing medical advice is extremely complicated. Providing medical advice online can be very challenging, but technology is becoming an enabler rather than a barrier. An expert system was used to guide towards major and minor decisions in breast cancer treatment, and the results were compared with experts and tumor boards in two international locations. The comparison was quite promising, showing that access to oncologist services can be facilitated through online means, supporting patients on a global scale.</p><h3><strong>Imagine a future where…</strong></h3><blockquote>More patients participate in research for cancer treatments<br>Less money is wasted in failing drug compounds<br>Patients manage their side-effects with less hospital visits<br>Doctors and patients can communicate like a team<br>Drugs are personalized for the highest chances of success<br>Patients have access to the latest reliable information<br>Early cancer detection is the rule, not the exception</blockquote><p><strong>These, and more, are within our reach.<br>Let’s work together and start making them happen.</strong></p><p></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c14624efb933" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Health 2.0 Europe 2016]]></title>
            <link>https://medium.com/@ThanosKosmidis/health-2-0-europe-2016-bbce36a67430?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/bbce36a67430</guid>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[tech]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Fri, 10 Jun 2016 08:39:25 GMT</pubDate>
            <atom:updated>2016-06-10T08:39:25.589Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*eoO06Jhy_Wy8r65DJx9THg.jpeg" /><figcaption>© Health 2.0 Events and Conferences</figcaption></figure><h3>Health 2.0 Europe: 2016 conference</h3><p>Digital Health, Med Tech, eHealth… and so many other names to describe the intersection of Technology &amp; Health. No matter how we may call it, the <a href="http://www.health2con.com/">Health 2.0 organization</a> is bringing us together across the globe with great conferences, full of interesting presentations, the latest demos, and plenty of networking opportunities.</p><p>In Europe, the regional conference takes place in Barcelona, which is emerging as an excellent place to host Digital Health leaders as well as new startups in this space.</p><p>Let’s dive in!</p><h3>EC-to-VC: Is European Digital Health “there” yet?</h3><p>As a great warm-up for the main conference… it was time for yet another EC2VC session, the 5th in this series, organized by the <a href="http://www.get-ehealth.eu/">GET</a> team. This was all about 11 pre-selected European Digital Health startups and the dozens of investors invited to watch their pitches. The <strong>winners</strong> were <a href="http://www.teckelmedical.com/">Teckel Medical</a> (in the “Seed/Early Stage funding” category) &amp; <a href="http://www.silvercloudhealth.com/">SilverCloud Health</a> (in the “Growth funding” category).</p><p>Before these winners were announced, however, there was plenty of time for interesting open-mic discussions across the room. <strong>The main topic was whether Digital Health has reached the desired point of maturity</strong>, especially when compared to the US.</p><p>Hence, we will focus on comments from two people in the audience who were actually invited from the USA:</p><ul><li><a href="https://www.linkedin.com/in/estherdyson"><strong>Esther Dyson</strong></a>, a prolific figure and investor. For Esther, regulation exists for a reason, and in healthcare, it is important to keep it in mind and face the minefield instead of avoiding it. She also made special reference to big data — and how it can really make a difference across the entire value chain. Furthermore, she emphasized the importance of data in post-marketing surveillance for drugs, and how it can help the entire industry figure out what is working and what is not. She completed her comments by reiterating <strong>how big the market and the opportunity is</strong> — calling on entrepreneurs to push forward with innovations that can make a difference<strong>.</strong></li><li><a href="https://www.linkedin.com/in/unitystoakes"><strong>Unity Stoakes</strong></a>, the co-founder &amp; president of Startup Health. Unity is well known for being a fan of big bets (including the “cancer moonshot” initiative, backed by the White House). He gave an encouraging overview of how he perceives the European digital health space to have evolved, as evidenced by the pitches as well as the other interesting businesses in the continent. His final message to European Digital Health entrepreneurs was very clear: <strong>Be bold</strong>.</li></ul><h3>Main Conference</h3><h4>Opening session &amp; Keynotes</h4><p>The opening session of the European Health 2.0 conference was again hosted by <a href="https://www.linkedin.com/in/matthew-holt-6b52"><strong>Matthew Holt</strong></a><strong> and </strong><a href="https://www.linkedin.com/in/plardier"><strong>Pascal Lardier</strong></a>. They spoke about the trends, the successes, the failures, and offered quite a bit of data. And in the end, they talked about …<strong>SMAC</strong>:</p><ul><li>Social</li><li>Mobile</li><li>Analytics</li><li>Cloud</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*9yjaFr47P956h_im3o6JAA.jpeg" /><figcaption>Esther Dyson at Health 2.0 Europe 2016</figcaption></figure><p>It was then time for <strong>Esther Dyson</strong> to deliver her much-awaited keynote, titled “Engagement is not just for patients”. The theme of her talk was around how digital health needs to engage the entire spectrum of stakeholders… but also how the software side needs to engage the patients. She highlighted the challenges brought on by the fact that patients (and the public at large) need to be “trained” in order to use the digital health services — and “untrained” from the habits and routines that still tie them to monolithic approaches. She ended her talk with a call to action for everyone: to <strong>cultivate an environment for health.</strong></p><p>Yet another keynote later in the day was delivered by a trauma surgeon: <a href="http://www.rafaelgrossmann.com/">Rafael Grossmann</a> is also known as “the <strong>Google Glass surgeon</strong>”, as he used this technology during live surgery. Dr Grossmann’s inspiration comes from Hollywood, which has demonstrated that it can really predict the future (albeit without much accuracy in terms of timing or design). He was adamant that technology can actually allow us to show more empathy, instead of the other way around — and this could be the driver behind his suggestion to “apologize, not seek for permission”.</p><h4>Other sessions</h4><p>Ipsos Healthcare presented the results of their <a href="https://connectedhealth.ipsos.com/"><strong>“Global Connected Health” survey</strong></a>, which was around type 2 diabetes but was drawing conclusions from a variety of fields. While many results were expected, perhaps the most important finding was that when it came to doctors’ experience and literacy on medical devices, <strong>doctors feel half as confident</strong> compared to how the patients/public perceive them to be.</p><p>A common theme of demos and discussion is around technologies &amp; solutions for Hospitals &amp; Healthcare professionals. During the corresponding session, interesting approaches were demoed by 6 companies of various sizes &amp; maturity. It was clear that the key criterion for adoption of such technologies is whether there is “<strong>clinical evidence</strong>” supporting that the benefits outweigh the risks and costs. Moreover, the size of the target “client” really matters in some cases.</p><p>There was an interesting panel on the building blocks to a dynamic Health 2.0 Ecosystem in Europe. The usual challenges were discussed, and the commonly accepted ingredients were brought up. Of course, the omnipresent <strong>challenge of raising investment in Europe for Digital Health</strong> was at the center of the conversation from panelists and the audience alike. And while there was consensus that many startups find it easier to go to Silicon Valley than staying in Europe, at least for funding… there were many who claimed that starting up in the Valley is so hard that if you can start in Europe then there are plenty of benefits to reap.</p><p>It is commonly accepted that data is the new currency in the Digital Health world. A great discussion was held around the topic of <strong>Data Analytics, and how information can be structured to drive decision-making</strong>. With the maturing ecosystem, and the various cases of decision support based mostly on data, data is proving its value and is claiming its position in the ecosystem. However, various business models have not fully materialized yet, making the monetization paths unclear for many players out there. The key challenge is to align the revenue model with the value chain being served — without alienating the data providers.</p><p>Last, but certainly not least: Behavior Change. It is the holy grail for many patient-facing technologies, and was the central topic of the “<strong>Coaching, Gamification and Design Strategies for Behavior Change</strong>” session. Many tactics were analyzed, and cases were discussed with key learnings brought home. The most successful efforts do not have the patients merely as objects in their processes: on the contrary, they manage to incorporate patients as the central actors in a process designed with them in mind.</p><h3>Challenges persist — but so do entrepreneurs!</h3><p>When health is at stake, the challenges are enormous. Technology, with all its might and promise, is never mature enough overall — and this is affecting its adoption at a large scale.</p><p>The Health 2.0 organization is making great strides in including many stakeholders in these events, which are really helping shape the discussion of adoption, revenue and reimbursement. However, sometimes more patients need to be involved in the overall conversation (and there indeed were a couple of sessions with patients on the panel, while the organizers also strongly encourage patients to attend). Personally, I would really want to see at least one patient in each and every one of these sessions: sharing their experience, giving their point of view about new technologies, and offering insights about what would improve their day-to-day lives.</p><p>Beyond this, though, either through reducing bureaucracy, enhancing point-of-care services, cutting down costs, or improving outcomes… <strong>Digital Health is here to stay. It is not a matter of If. It is only a matter of When.</strong></p><p><em>Note: The </em><a href="http://www.health2con.com/ticket/10th-annual-fall-conference/"><em>10th annual Health 2.0 fall conference</em></a><em> is taking place September 25–28 2016 in California (Santa Clara).</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=bbce36a67430" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Essential engineering skills in digital health]]></title>
            <link>https://medium.com/found-ation-bits-pieces/essential-engineering-skills-in-digital-health-203bfb78534?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/203bfb78534</guid>
            <category><![CDATA[jobs]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[recruiting]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Mon, 15 Feb 2016 22:26:40 GMT</pubDate>
            <atom:updated>2016-02-15T22:49:51.388Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*3UHNkr4sh5_tMoUbjBzsvw.jpeg" /></figure><h3><strong>Essential engineering skills in Digital Health</strong></h3><p>Digital Health represents the fast-growing industry at the intersection of healthcare and technology. From the hospital to the home, from the outdoors to the gym, it is becoming an increasingly important part of our lives.</p><p>For engineers, it represents an area of enormous opportunity, but can hide many challenges. What follows is an outline of the key skills and competencies that an engineer must possess to thrive in digital health.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/390/1*OpBj0usOZFTP5L0cD6ZMMQ.jpeg" /></figure><h4><strong>Design</strong></h4><ul><li>Designing websites, apps and interfaces for digital health is particularly difficult. One of the key challenges is related to the <strong>different target demographics</strong>. In particular, while most digital design patterns, templates and themes cater to the younger generation, many healthcare-related technologies are built with the somewhat older user in mind. Therefore, the designer of a digital health service should be ready to investigate deeper into the services’ target audience and identify the best way to produce a modern yet comfortable design and interaction. For instance, a web application for heart conditions can be very different to one for exercise and fitness.</li><li>It is applies to most services, especially healthcare: <strong>we are not our own customers</strong>. The User Interface/User eXperience (UI/UX) of a digital health service must be able to adapt to the user journey, based on the particular interaction and value proposition. Some healthcare services start with the symptoms, and evolve into diagnosis and treatment. Others focus on chronic conditions whose treatment (and, thus, online interaction) is much longer and includes many milestones. For example, consider the differences of a service to aid people suffering from depression, and compare it to one supporting epilepsy patients.</li><li>Have you ever come across a site that doesn’t seem trustworthy? Unless you are a designer, you may not be able to identify the reasons you feel this way. However, <strong>in healthcare, reliability and credibility are of utmost importance</strong>. The designer must be well-versed in the elements that can convey these qualities, including colors, fonts, images, animation etc. A platform for cancer patients needs to build much more trust and project more authority, compared to most running companion applications, for instance.</li><li>Given the increasing uptake of mobile browsing, it goes without saying that any website out there must be <strong>responsive</strong>. However, the limitations of mobile devices must be acknowledged, and the designer should carefully apply the usability best practices to the specific needs of the website’s users. Consider, for example, how difficult it is for most users beyond a certain age to stay focused on a small mobile screen and tap — particularly if the website provides rich media or complicated medical terminology. And keep in mind that not all of your users have the latest iPhone!</li></ul><h4><strong>Front-end Development</strong></h4><ul><li>Web developers who have worked on medical websites have grown accustomed to rigid structures for each webpage, especially if it includes forms for <strong>medical data entry</strong>. While this is no longer entirely true, input and interaction are still very important in the digital health realm; some people regard entering their credit card details less stressful than medical data. It is important for the web developer to work closely with the medical expert on the team in order to help users cut through the long names and repetitive input. Haven’t you wondered why your hospital needs your medical history every single time? Let’s fix that.</li><li>Browsing speed is of the essence when one is concerned about their health or diagnosis, and it is an opportunity for a developer to shine. Use every tool in your arsenal to <strong>make the experience as quick and smooth as possible</strong>. For instance, large, high-resolution images are common in healthcare and medical practice (and can be multiple MBs in size); allow the uploading of a pathology report to be done in the background; use modern frameworks that reduce page reloads, etc.</li><li>Put your hand up if you like <a href="http://gs.statcounter.com/">old, outdated browsers</a>. Yep, nobody does — except the IT departments of large corporations and organizations (including hospitals, medical offices, insurance companies, etc), and those middle-aged people who have a desktop computer and change their mouse pointer daily, for fun. Well, guess what, they are your users and your customers, and they come first. An experienced front-end developer will work with the rest of the team to enable <strong>cross-browser compatibility</strong>, optimize the interaction across browsers, and balance the bleeding-edge with what the user wants.</li><li>It should be a given, but building secure websites and applications is still a challenge. <strong>Security and confidentiality</strong> of medical data is of paramount importance and all user inputs must be properly validated and tested with all the corresponding injection scenarios. Equally important is for the developer to stay on top of the latest breaches and lead the effort to keep the front-end secure, and the users confident.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/682/1*gOTHnGUrVHCxB4fY0Wn_ZQ.png" /><figcaption><em>Yes, sometimes an algorithm is necessary to diagnose obesity</em></figcaption></figure><h4><strong>Back-end Development</strong></h4><ul><li>Behind the scenes of a great digital health solution is a set of well-engineered back-end components. The developer should be familiar with the established ways that can enable rapid evolution of this otherwise rigid infrastructure. The back-end developer who is experienced in <strong>design patterns, modern frameworks, modularity and extensibility</strong> will excel — and help build a service that can adapt much faster than the monolithic healthcare systems of our times.</li><li>The spectrum of digital health solutions is very broad — but can raise substantial challenges if the back-end is not engineered properly. For example, imagine a service initially built for multiple sclerosis patients to coordinate with their caregivers; after increased adoption and broader interest, the company behind the service decides to offer it to diabetes patients as well. If the back-end developer has built the <strong>components in a modular, abstract way</strong>, most of the logic and data elements will be reusable without much modification.</li><li>No solution is an “island”: <strong>integration with third-party services</strong> is quite common among mature digital health services. If you are a developer experienced in synchronous and asynchronous API calls, callbacks, message queues, deadlock prevention and so on, you will help the platform scale well and offer great benefits to its users.</li><li>Clearly, intimate knowledge of databases is a must for any back-end developer. For a digital health solution, it is important to understand the <strong>depth of data that may need to be collected</strong>: clinical and medical data is notoriously complicated, with rigid structures and <a href="http://www.who.int/classifications/icd/">important standards</a>. Furthermore, and depending on the desired user interaction and experience, the database design must balance the principles of normalization with the speed of operations as well as the desired expandability of the solution.</li></ul><h4><strong>Architecture</strong></h4><ul><li>In healthcare, the <strong>privacy, security and anonymity</strong> of data is everyone’s job. But the burden falls on the Architect’s shoulders to ensure that the ever-increasing data collection requirements of the business observes the most stringent data protection measures available. Regardless of the company’s size, regardless of the job title, the overall architecture must respect the users’ wishes, and the law. Some software architects feel uncomfortable having to follow such complicated and often unclear guidance, but for digital health this is an essential skill.</li><li>Current trends and economics point to a <strong>cloud-based, tiered architecture</strong>. This is not rocket science; it is essential for the architecture lead to be familiar with the intricate details of IaaS, PaaS, SaaS, etc., and what they mean for the software, the company and its users and clients.</li><li>Architectures can be notoriously complicated, or swift and simple. No user really cares, as long as they are extensible and can cater to today’s needs as well as future evolution. This is why having a <strong>flexible architecture following solid principles</strong> is important for the long term prospects of a digital health company. Furthermore, it is always important to keep data and devices in mind when constructing and updating the architectural blueprint.</li><li>“<strong>Open data</strong>”: if you have not heard about it, fear not — it is the industry’s way of saying “we need to ensure interoperability and flexibility of data sharing for healthcare”. In practice, this means that the 20th century way of hiding data and metadata is no longer viable. And digital health technologists must lead the way in sharing and leveraging data for the benefit of their users and clients.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/638/1*tEOfPP-xYzNC7G6ofCzFzg.jpeg" /><figcaption>Credit: <a href="https://www.flickr.com/photos/curiouslee/14054644300">Mike Lee</a></figcaption></figure><h4><strong>Hardware engineering</strong></h4><ul><li><strong>Wearables and other devices</strong> are fast becoming the latest trend in digital health. Most of them are actually related to fitness (i.e. not necessarily health) but that does not diminish their value. In terms of fitness, and if we accept that very little “fitness” comes with stationary life, the key word is “<a href="http://www.dimensionengineering.com/info/accelerometers">accelerometer</a>”. Starting with custom devices, and early smartphones, this set of capabilities allows devices to detect movement to a decent approximation. And it is an important skill for a hardware engineer in digital health!</li><li>Imagine a medical device that you wear on your wrist, which reads an array of values from your skin, the environment, anywhere. This is where <strong>sampling techniques</strong> become very important. Their <a href="http://www.usatoday.com/videos/tech/2015/05/01/26678643/">failure</a> (?) has been widely publicized. And failing to get this right is like building a website that does not load.</li><li>Would you want to wear a fantastic medical device on your wrist, if it weighed half a kilo? Didn’t think so. A lot of progress has been made to <strong>bring down the weight</strong> of these devices, and knowing how to do this without diminishing the value and accuracy is certainly a very advantageous skill.</li><li>Would you buy <a href="http://www.apple.com/watch/battery.html">a watch with a battery that lasts 18 hours</a>? Perhaps. A lot of innovation these days comes in the form of reducing power drain and thus<strong> </strong>increasing<strong> battery life</strong>. If you can do that with smaller, lighter batteries, more power to you (excuse the pun)!</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*-nPWN4CaBAzRkupFJG6W7Q.jpeg" /><figcaption>Credit: <a href="https://www.flickr.com/photos/intelfreepress/7897619082">Intel Free Press</a></figcaption></figure><h4><strong>Mobile apps</strong></h4><ul><li>Mobile apps represent the bulk of consumer digital health solutions nowadays. Designing a mobile app can be quite straightforward, but doing it right is as complicated as ever. As with any mobile app, getting the visuals and notifications right are essential. For bonus points in digital health applications, one needs to focus on <strong>engagement and interaction</strong>, which must respect that the usage patterns in healthcare applications are very different from the entertainment or communications apps.</li><li>Take it easy with <strong>integrations &amp; notifications</strong>: some people may want to be notified when they have had too much cake, but the challenging thing about health is that we only pay real attention to it when we are sick. And when you’re sick you want solutions — not to link your Twitter account with your blood pressure monitor. An engineer who is empathetic and can relate with the target audience is a rare breed here.</li><li>Borrowing done right is a talent. When the most trendy app starts featuring swiping left and right to indicate preferences, for instance, chances are that the shift will affect most applications. However, engineers should not lose sight of <strong>the customers’ journey</strong>, and their particular, healthcare-related needs.</li><li>If you’ve worked on an app before, you know the #1 problem: <strong>Discoverability</strong>. This is where the intersection of product management, marketing, design, engineering, and growth hacking shines. Being an engineer, you can do all of these simultaneously J. To get your app discovered, downloaded and used, the focal point must, once again, be the “customer’s journey”. For instance, getting a prescription prepared through a previously unknown app for the first time is probably not the best idea when you’re already sick. The good thing is that your customers’ pain may be so clear that you could just ask for their preferences. Of course, this may a bit too much to ask from engineers — but think about the benefits of co-designing your apps with your customers.</li></ul><p>If you found that these are skills you already possess, then you may be ready for a career in the promising field of <strong>digital health</strong>.</p><p>And, regardless, don’t miss the opportunity to enter the <a href="http://techtalentpool.gr/">Found.ation Tech Talent Pool</a> and increase your chances of landing that dream job!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=203bfb78534" width="1" height="1" alt=""><hr><p><a href="https://medium.com/found-ation-bits-pieces/essential-engineering-skills-in-digital-health-203bfb78534">Essential engineering skills in digital health</a> was originally published in <a href="https://medium.com/found-ation-bits-pieces">bits &amp; pieces</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[You have cancer, now what? The tech version]]></title>
            <link>https://medium.com/healthcare-in-america/you-have-cancer-now-what-the-tech-version-b4b54695fb3f?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/b4b54695fb3f</guid>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Thu, 14 Jan 2016 16:43:34 GMT</pubDate>
            <atom:updated>2018-06-19T02:35:12.747Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6uzNbLK1ELi6QB16pPv8Kg.jpeg" /></figure><p>Ask any cancer patient about their cancer journey, and they will likely begin with the moment they received their diagnosis. It is a stressful, frightening and overwhelming experience.</p><p>Nobody is prepared to hear the words “You have cancer”.</p><p><strong><em>Cancer is more common than you think</em></strong></p><blockquote>1,000 people hear these words every single day in the UK.<br>500 in Canada.<br>5,000 in the USA.<br>10,000 throughout Europe.</blockquote><p>Most of these cases are in the <strong>lung, breast, colon</strong> or <strong>prostate</strong>; <strong>stomach </strong>and <strong>liver </strong>cancer are also among the more common diagnoses globally. Beyond these and other types of cancer, there are literally hundreds of rare cancer types, which together account for <a href="http://www.rarecarenet.eu/rarecarenet/">22% of cancer diagnoses</a>.</p><p>This article aims to explain how technology can help anyone just diagnosed with cancer of any type.</p><p>And it all starts with knowing what the C word really stands for.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*M5f6AsPfXYfVo6Vk9HfN4Q.jpeg" /></figure><h4><strong>Technology to help understand a cancer diagnosis</strong></h4><p>In order to understand a cancer diagnosis, one needs to know what cancer really is: an extremely complicated condition, with many different types and sub-types. If that was not enough, <em>metastatic disease</em> (which describes a condition that has spread beyond the original location) adds even more complexity.</p><p>There is little doubt that most patients and caregivers turn to the web in order to find out more about their diagnosis. Unfortunately, not all online sources are reliable and accurate (some of them are even deceiving). <em>Online health material must not induce fear or confusion.</em> Instead, a brief and balanced explanation of the key cancer types, together with references for those who want to read more, can really make a big difference for someone who just received a diagnosis.</p><p>It is important for patients to understand that an exact cancer diagnosis may include a lot of information. For instance, <em>compare between these two diagnoses:</em></p><ol><li>“breast cancer”</li><li>“2cm, stage 2 grade 1 invasive ductal carcinoma in the left breast, with clear margins, 2 lymph nodes involved, estrogen-positive and progesterone-negative, with overexpression of the HER2 protein”.</li></ol><p>Perhaps the centerpiece of the diagnosis is the <em>Pathology Report</em>. With technology’s help, patients should be able to decipher each piece of that report and compose a concrete and comprehensible view of their own diagnosis. The goal here is not to turn patients into pathologists, but to explain what is happening in their own body.</p><h4>Making important decisions</h4><p>Achieving a good understanding of the diagnosis helps to lay the foundation for the next steps. While technology cannot replace a doctor’s experience and clinical examination, it can be instrumental in highlighting specific decision points based on the exact diagnosis. These include:</p><ul><li><strong>Fertility options</strong>: Depending on age, gender and family planning, some patients want to know their options for preserving their fertility after treatment. This is particularly important in some types of cancer, as well as for specific treatments. Digital health tools can highlight the key options and guide patients towards a fruitful discussion with an “onco-fertility” expert. <em>It may seem obvious, but </em><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364765"><em>some</em></a><em> </em><a href="http://uk.reuters.com/article/us-health-fertility-cancer-idUKKCN0Q124D20150727"><em>reports</em></a><em> have documented limited discussions around this important topic.</em></li><li><strong>Molecular Diagnostics</strong>: Some tumors are characterized by a genetic signature, which in turn can support diagnosis, prognosis as well as treatment decisions. Therefore, for those patients, it is very important to conduct molecular diagnostics on the tumor (generally via tissue or blood testing). This is, after all, the basis of personalized medicine in oncology. Technology applying basic rules on a cancer diagnosis can help patients understand whether they could benefit from such testing. <em>Interestingly, even in the UK, many “eligible” patients seem to be </em><a href="https://www.cancerresearchuk.org/sites/default/files/policy_august2015_mdx_final_1.pdf"><em>missing out on these opportunities</em></a><em>.</em></li><li><strong>Companion Diagnostics</strong>: Similarly to molecular diagnostics, companion diagnostics (often abbreviated <em>CDx</em>) help clinicians determine whether a specific treatment has higher likelihood to help the specific patient. These tests can be expensive, but are sometimes required in order for oncologists to prescribe these treatments, identifying which patients stand to benefit most is crucial — and digital health technology can help.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/958/1*61KkZMsPU7LybQ064kWV5Q.jpeg" /></figure><h4><strong>Getting a second opinion</strong></h4><p>There are many reasons it is hard to be a doctor: you cannot always be sure, and sometimes you may be wrong. When someone faces the intense emotions associated with a cancer diagnosis, the urge to confirm the diagnosis can be overwhelming. Therefore, getting a second opinion is the norm (and is often encouraged by experienced doctors).</p><p>Increasingly, a second opinion is being sought online. This may include sending pathology to an online service, and receiving a diagnosis based on the supplied information (usually for a fee). This can be particularly helpful when there are no designated and experienced cancer clinics nearby. While large hospitals have been providing such services for a few years, there is an growing number of independent providers offering second opinion services.</p><h4><strong>Finding the “best doctor for me”</strong></h4><p>A patient diagnosed with cancer needs to decide their next steps. Choosing the “right doctor” is one of them.</p><p>As already discussed in a <a href="https://medium.com/@ThanosKosmidis/tech-vs-cancer-the-path-to-diagnosis-6f9eb6c0189b">previous article</a>, there are plenty of online services helping patients identify the right doctor. A service can be more helpful to cancer patients if it can focus on the exact cancer type, and enable reviews and opinions from the community. However, it is important to realize that “the wisdom of crowds” can be misleading when it comes to choosing an oncologist. This is because no two cancers are the same, and the relationship can be quite personal and different for each of us.</p><h4><strong>Summary</strong></h4><p>Too many of us will hear the words “you have cancer” at some point. That will be a moment we will want to forget, but will never manage to.</p><p>There is no cure yet. There is no silver bullet either.</p><p><strong>But one day, the first prescription given to someone with cancer will be a “healthy dose of digital health”.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b4b54695fb3f" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthcare-in-america/you-have-cancer-now-what-the-tech-version-b4b54695fb3f">You have cancer, now what? The tech version</a> was originally published in <a href="https://medium.com/healthcare-in-america">Healthcare in America</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Tech vs Cancer: the path to diagnosis]]></title>
            <link>https://medium.com/@ThanosKosmidis/tech-vs-cancer-the-path-to-diagnosis-6f9eb6c0189b?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/6f9eb6c0189b</guid>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[health-technology]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Mon, 14 Dec 2015 14:50:41 GMT</pubDate>
            <atom:updated>2015-12-14T14:50:41.953Z</atom:updated>
            <content:encoded><![CDATA[<h3>Technology vs Cancer:</h3><h4>Can Digital Health support those worried they may have cancer?</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*uhReMrE9aYgfPWrSYtX3Fw.jpeg" /></figure><p>Have you ever worried that you’re ill?<br>That you may have the flu?<br>Sinusitis?<br>A viral infection?</p><p><strong><em>What about cancer?</em></strong></p><p>This is the fear paralyzing thousands of people every day.</p><p>This fear may start with…:</p><ul><li>a lump in the body</li><li>a persistent cough</li><li>a strange-looking mole</li><li>blood in the toilet bowl</li><li>pain (that could be dull, sharp or burning)</li><li>skin discoloration</li></ul><p>…or a number of other signs.</p><p><strong>Can technology help those worried about cancer? What can be done to support decision-making? Can digital tools make the path to a cancer diagnosis less burdensome?</strong></p><h3><strong>Technology along the journey to a cancer diagnosis</strong></h3><p>People will always get cancer. I probably have cancerous cells in my body right at this very moment — just not enough to form a tumor (or so I hope).</p><p>Helping those worried about cancer through technology is becoming important, because:</p><ul><li>It no secret that <strong>people already search for health-related information online</strong>. Actually, middle-of-the-night searches for symptom are not uncommon. It turns out that, when the question is “could it be cancer?”, everything else can wait (including that post on social media).</li><li><strong>Healthcare systems are over-stretched</strong>: as more people decide to visit a healthcare professional to deal with their fear, systems become less functional. In some extreme cases, the system starts undermining its own goals. For example, it was recently reported in the UK that <a href="http://www.theguardian.com/society/2015/oct/01/gp-practices-offered-rewards-for-not-referring-patients-to-hospitals">GP practices had been offered rewards for not referring patients to hospitals</a>. People can <strong>spend weeks waiting in agony for an answer, </strong>while in some countries, fragmentation of care leads to frustration. And none of these are good if you are worried you may have cancer.</li><li>Cancer is now an undeniable <strong>part of our society</strong>. Famous people get it. Past Presidents get it. Celebrities get it. Neighbors get it. In the UK alone, <a href="http://www.macmillan.org.uk/Aboutus/News/Latest_News/25millionpeoplenowlivingwithcancerinUKMacmillanrevealstoday.aspx">2.5 million people are estimated to be living with cancer</a>; if that’s not enough, <a href="http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2015-02-04-1-in-2-people-in-the-uk-will-get-cancer">half of those living today are expected to get cancer at some point in their lives</a>.</li><li><strong>Psychology</strong>, and fear of the unknown play strange games in our fast moving world. Even if we have been thinking that “it will not happen to me”, the slightest sign or symptom may switch this to “I can’t believe it is happening to me”.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1hZQC5ufw8wGuq4YduNwtg.jpeg" /></figure><h3>A Digital Health approach</h3><p>Sometimes, when you have a hammer, everything looks like a nail.</p><p>However, it is important to realize that technology is not the one and only answer. Most of us tend to oversimplify healthcare, to design for the average person and the average situation, and to extrapolate our own situation and preferences.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*DUfl-L43l_bMWHrPMcFdGg.jpeg" /></figure><p>Therefore, it is critical to <strong>balance </strong>the application of technology in this case. This includes signposting, triaging, and managing expectations. Moreover, it is important to design for those whose agony is leading them into dark corners, even in the middle of the night.</p><h4><strong>Personas</strong></h4><p>The individuals worried about cancer and using technology for guidance (or even self-diagnosis) do not belong to a single category. Building personas is a necessary part of the service design process.</p><p>Let’s look into a few relevant “personas” below:</p><ul><li><strong>The hypochondriac</strong>: we all know them (or look at them in the mirror every day). They have enviable attention to detail, which leads them to believe they are infected, sick, or dying. Technology must acknowledge this kind of thinking, but not fuel it. This is where most of the online resources fail, as symptomatology cannot be precise, complete or exclusive. The goal here is to manage expectations and clarify that properly analyzing and evaluating signs and symptoms requires a process, and comes with no easy answers.</li><li><strong>The close relative</strong>: when a loved one suffers, we suffer too. Caregivers may get overwhelmed whenever something leads to a suspicion of disease. In this case, common sense may fail us. Any service aiming to help those worried about signs and symptoms should highlight that no two cases are identical, as well as carefully explain the genetic or familial aspects of certain conditions.</li><li><strong>The one always on alert</strong>: how many times have you heard or read about risk factors, warning signs, or other tidbits that make you worry you are unhealthy? There are hundreds of new research pieces coming out daily that can drive even the most composed citizen absolutely nuts. The goal of a service catering to this audience must help put “news” in the right context, without taking away their thirst for knowledge.</li><li><strong>The one who just want to make sure</strong>: Something has been bugging them for a while, but they have been putting off looking into it for any number of reasons. Their quest is one for confirmation that they are just overreacting. This one’s “easy”! But what if they are not — and they need to delve further? Balance is again the key word: Self-diagnosis has its merits but working with an expert is irreplaceable.</li></ul><h4>Information</h4><p>A service to explain signs and symptoms is predominantly an information-based service. <strong>Fear of cancer may be fueled by any number of things, but its best ally is lack of adequate information, or the misinterpretation of the existing information</strong>.</p><p>As a consequence, such a service should help the worried ones<br>- understand that cancer is a simple word for a set of hundreds of conditions<br>- identify what cancer is, in simple terms<br>- dispel myths about cancer, its signs and symptoms, or risk factors<br>- prepare to guide themselves through the maze of tests, potential diagnoses, and their implications.</p><p>Furthermore, should this trigger the beginning of a journey towards cancer diagnosis, it is important to help <strong>manage expectations</strong>. This journey is not easy, simple, or painless. And while most of us are familiar with the concepts of chemotherapy, surgery, radiation therapy and other necessary evils, the almost-universal truth is that cancer is a rollercoaster ride.</p><p>Moreover, one cannot emphasize enough the importance of the psychosocial side of cancer. <strong>Isolation, fear, depression and anxiety</strong> are not uncommon; knowing that they can be part of the journey is not reassuring by any means, but it is important to know that they do happen and that there are ways to ameliorate their impact.</p><h4>The right tools</h4><p>Technology sometimes feels like a garage full of tools, inviting us to experiment with them. While the capabilities in healthcare are endless, the public’s best interest demands a balanced approach.</p><p>Consider these tools:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/983/1*XHR5lHay6yIzd3LFnU5OnQ.png" /></figure><p><strong>Symptom checker</strong>: Imagine a way to enter your symptoms and getting a diagnosis. It sounds simple: you would just need to pick out of a list of possible symptoms, and your diagnosis would be one click away. Well, there are reasons that doctors are not all that concerned about being replaced by a machine to diagnose cancer: it is more complicated than that. Not only is cancer a term “hiding” multiple conditions, it can also be hard to diagnose. <em>There are countless stories of patients who had to reach out to multiple specialists before getting the right diagnosis. </em>This may be due to unclear symptoms, unclear imaging or biopsy outcomes, human errors and other reasons. As with any application of technology, it is critical to identify which problem it is solving: until (if?) diagnosis becomes completely automated, a symptom checker must:</p><ul><li>Help patients understand their own symptoms</li><li>Rule out any conditions as applicable</li><li>Guide them to the right kind of expertise (e.g. gynecologist vs medical oncologist)</li><li>Instill the right sense of urgency (which is often misunderstood by those worried: cancer generally evolves slowly).</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/432/1*mjEI8jAwU1Rz78SNLm_RsQ.png" /></figure><p><strong>Genetic risk assessment</strong>: Substantial research is being conducted to understand the genetic causes of cancer — and much more is still necessary. To date, some specific genetic predisposition syndromes have been identified, including those leading to breast and ovarian cancer, as well as colorectal cancer. <em>Overall, about </em><a href="http://www.cancer.org/cancer/cancercauses/geneticsandcancer/heredity-and-cancer"><em>5–10% of cancer cases are due to an inherited gene mutation.</em></a> A genetic risk assessment based on scientific guidelines can help identify high familial risk of cancer. It is important to note that such a tool does not diagnose cancer but performs the (very important) task of risk stratification. On the other hand, a careful and well-rounded implementation can really assist high-risk individuals during the next steps.</p><p>This means helping them:<br>- realize what “high-risk” and “normal risk” means, and what is behind their individual case<br>- understand that there are specific tests available to further validate any risk stratification<br>- become familiar with some of the available options in case these tests indicate a genetic mutation (and realize that doing nothing is an option, too)<br>- identify and collect the necessary documents and family history<br>- prepare to share these with a cancer genetic counselor, in order to thoroughly discuss their individual case and the best next steps.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*PmpWcsmqIuR7aTWsUss_dg.png" /></figure><p><strong>Epidemiology report</strong>: Epidemiology breaks down medical conditions into patterns, statistics and other data points. It is the branch of medicine which reveals that, for instance, men are most vulnerable to testicular cancer in the age bracket of 40–44, or that Latvia has the highest incidence rate of ovarian cancer. While such high-level statistics can be almost dangerous if applied blindly to an individual case, they do have a place in <em>guiding screening procedures, and calming the inner voice which can drive some people paranoid at the slightest sign of cancer.</em> Therefore, such a report can “translate” generic epidemiological data into specific relative risk based on demographic data.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/360/1*9yrWUOQN_F49VlbLbg7d3Q.png" /></figure><p><strong>Finding “the right Doctor”</strong>: When all is said and done, the need to find and facilitate an appointment with a medical professional is crucial. Such a service can help identify the right professionals based on various criteria — as many such platforms are already doing. Criteria include location, reviews, board certification, insurance companies, professional affiliations, etc.<br>Such a tool will be even more helpful if it can help gather the right information and documents (from lab tests to personal and family health history to the timeline of symptoms and signs). In case it can be integrated with doctors’ workflows, it could even help them prepare for the appointment by guiding them to do some “homework” in advance — staying on alert for possible misdiagnoses or learning about additional data that could be necessary. <em>This is particularly important in suspected cases of rare cancers, or when referral documentation must be shared between healthcare professionals.</em></p><h3>No easy answers</h3><p>There are two kinds of technological breakthroughs: the ones that give you the answer, and the ones that show you the way to the answer.</p><p>In most cancer cases, technology is not ready to give an outright answer. But we are very close to helping those who are worried through the maze of information and decisions.</p><p>At the end of the day, the best way to treat cancer is to diagnose it early; and while the statistics are not on humanity’s side, <strong>technology can help make up the lost ground</strong>.</p><p><em>Image credits: </em><a href="https://www.flickr.com/photos/novecentino/1187953915"><em>Giorgio Montersino (Flickr)</em></a><em>, </em><a href="https://www.flickr.com/photos/maxwellgs/4267311036"><em>Maxwell GS (Flickr)</em></a><em>, </em><a href="https://thenounproject.com/term/checklist/5166/"><em>Aaron Dodson (from the Noun project)</em></a><em>, </em><a href="https://commons.wikimedia.org/wiki/File:Malignant_neoplasms_world_map_-_Death_-_WHO2004.svg"><em>Lokal Profil (Wikipedia)</em></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6f9eb6c0189b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The unbalanced startup scorecard:]]></title>
            <link>https://medium.com/the-startup-magazine-collection/the-unbalanced-startup-scorecard-650db553c3e7?source=rss-89fa638e0e24------2</link>
            <guid isPermaLink="false">https://medium.com/p/650db553c3e7</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[london]]></category>
            <dc:creator><![CDATA[Thanos Kosmidis]]></dc:creator>
            <pubDate>Mon, 07 Sep 2015 10:22:49 GMT</pubDate>
            <atom:updated>2015-09-07T17:36:53.849Z</atom:updated>
            <content:encoded><![CDATA[<h2>London vs Athens</h2><p>It was only while rushing to get to the tube amidst a summer storm that I realised it: the last summer I spent in London was 16 years ago.</p><p>In 1999, during my degree’s “industrial placement”, I worked at a large investment bank. It was during the bull period for the world’s financial markets, and the spirits were high in the City.</p><p>Within 16 years, change is inevitable. Some happened through specific ‘black swan’ events: another investment bank, occupying the floor right below my then-office, filed the industry’s <a href="https://en.wikipedia.org/wiki/Bankruptcy_of_Lehman_Brothers">most consequential bankruptcy</a> in 2008. Other changes came about more gradually: The Olympics reshaped the city and helped absorb the crash (at least within the real estate industry); Shoreditch, from downright dodgy, has become hip and filled with startups.</p><p>Fast forward to today, and it is this level of intense activity that brings me here again: our digital health startup <a href="https://www.careacross.com/">Care Across</a> is part of the <a href="http://www.masschallenge.org.uk/">MassChallenge UK</a> accelerator.</p><p>But shortly after touch-paying for my £2.90 tube ride, the trail of thought led to Athens: my “home city”, in a country that has been battered, unstable, and with the uncertainty of its junk bond status. Charting its 16-year course would be challenging (as I’ve moved cities a few times since then), but it was inevitable to start the comparison engine…</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_omC-Y3MYTkMEePBmbce7A.jpeg" /></figure><p><strong><em>London vs Athens: for a startup, is it even a contest?</em></strong></p><p>You may be in for a surprise.</p><h3><strong>Overall vibe</strong></h3><p>You can’t escape the bustling activity of <strong>London </strong>— even if you’re just flying over it.</p><p>Above ground, there are cranes everywhere for new developments — offices for more companies or buildings for more students, professionals and families to call home. On the ground, the number of co-working spaces and events is growing and still reaching capacity, as more and more people of all ages start out on their own or want to feel part of the ever-growing community. (Case in point: only a couple of weeks before the MassChallenge UK programme kicked off in June, its <a href="http://tobaccodocklondon.com/">Tobacco Dock</a> headquarters were virtually unrecognisable — and now 90 startups are fighting against time and established competitors, often armed with little more than passion and caffeine.)</p><p>As for under-ground… well, if this is any indication, the London Underground service is expanding with more lines under construction, and aims to <a href="https://tfl.gov.uk/campaign/tube-improvements/the-future-of-the-tube/night-tube">start operating 24x7 this fall</a>. Never mind the gap, the tube’s on tap.</p><p><strong>Athens </strong>is no sleeping city — although sometimes for the wrong reasons. And while I still find it hard to stay at a café for more than half an hour (I need 5 minutes to drink my coffee, unless I’m in a rush), the activity levels in most central areas never stops. There is something remarkable about the resilience of a population that seems to find the way to connect with each other and enjoy life beyond the uncertainty and feeling of impending doom. In some parts of town, the numbness from years of economic downturns, political unrest and fear of the future has given way to creativity, restlessness and a long-lost entrepreneurial spirit. Students come together to work on various projects, young professionals start companies, and the word “ecosystem” is firmly back in our vocabulary.</p><h3><strong>Institutional support</strong></h3><p>A couple of years ago, I came across the term “<a href="http://www.techcityuk.com/">Tech City</a>”. Part of the language used by <strong>London</strong>’s political and social forces about pushing the City beyond its financial heritage, it has led to a rapid shift in the balance of talent, industry sectors and investment criteria. It is the same thinking that led to <a href="http://www.bmmagazine.co.uk/in-business/boston-london-join-forces-launch-new-10m-startup-accelerator/">the Prime Minister and the City welcoming MassChallenge</a> with open arms here: a US establishment for talent and entrepreneurship, for the first time reaching out to the old continent. Now the City supports multiple initiatives, ranging from co-working spaces to co-investment schemes, a new economy that appears to be singing some of the new tunes that London is dancing to.</p><p>In <strong>Athens</strong>, the word “institution” has gotten a bad rap. The only support most locals want from institutions is to get out of the way (although whenever such support does arrive, it is sought after with server-crashing passion). The more maturing and composed views call for more solid and balanced structures and measures to be put in place, including those that allow for longer planning. That would be a real “innovation” for citizens who will be told this year’s income tax rates about a year later.</p><h3><strong>Funding</strong></h3><p>In 2012, Her Majesty’s Revenue and Customs (HMRC) introduced generous tax incentives (the <a href="https://www.gov.uk/government/publications/the-enterprise-investment-scheme-introduction">Enterprise Investment Scheme</a> and its <a href="https://www.gov.uk/guidance/seed-enterprise-investment-scheme-background">Seed equivalent</a>), enabling individual investors to drastically recalibrate their risk-reward profiles. This greatly benefits <strong>UK</strong> investors, startups and SMEs, and the overall economy in a really decisive manner.</p><p>Beyond the government’s measures, though, venture capital is in no short supply, with firms seeking to invest slightly higher amounts than before but still eager to participate early on.</p><p>In <strong>Greece</strong>, on the other hand, is still clear as mud in terms of its incentives to investors. Thankfully, the European Investment Fund has helped catalyse a lot of funding activity through national Jeremie funds: The <a href="http://theopenfund.com/">OpenFund</a>, <a href="http://www.pjtechcatalyst.com/">PJ Tech Catalyst</a>, <a href="http://odysseyvp.com/">Odyssey Venture Partners</a> &amp; <a href="http://www.elikonos.com/">Elikonos</a>. Together with the startups they have invested in, they have made the news from Greece so much more positive.</p><h3><strong>Cost of living</strong></h3><p>Apparently, <a href="http://www.expatistan.com/cost-of-living/comparison/athens-greece/london"><strong>London</strong> is 2.29 times more expensive than Athens</a>. Not only that, but it keeps getting more expensive, and even <a href="http://www.theguardian.com/money/2014/jun/02/londoners-flocking-out-capital-exploit-house-price-gap-property">pushing more people outside the M25</a>. This breeds interesting dynamics for companies moving here to take advantage of the positive economic climate and other benefits. Thankfully, however, entrepreneurs are (or should be!) lean, and there is plenty of office space available for attractive prices (thank you again MassChallenge UK!).</p><p>So what does this make <strong>Athens</strong>? Affordable, at least. <a href="https://translate.google.com/translate?sl=el&amp;tl=en&amp;js=y&amp;prev=_t&amp;hl=en&amp;ie=UTF-8&amp;u=http%3A%2F%2Fstartupper.gr%2Ffound-ation-%25CF%2580%25CF%2581%25CE%25BF%25CF%2583%25CF%2586%25CE%25BF%25CF%2581%25CE%25AC-%25CE%25B3%25CE%25B9%25CE%25B1-open-space-work-station%2F&amp;edit-text=">Co-working spaces are offering good rates for startups</a>, service providers are willing to drive prices low for any business they can get, and real competition is beginning to actually work. Importantly, startups are beginning to collaborate instead of hiding from each other. Case in point: <a href="http://tech.eu/news/greek-startups-pay-it-forward/">entrepreneurs getting together to help others affected by the recent capital controls</a>.</p><h3><strong>Talent</strong></h3><p><strong>London </strong>enjoys high quality, well-educated talent from its own top universities, as well as talent coming from other parts of the UK. It also attracts large number of graduates from everywhere in the world who arrive here to reap the benefits of its rapid pace, strong financial markets, as well as social and cultural activities. A more important component in the talent equation is their level of experience: a bachelor’s degree in the UK lasts 3 years, allowing 21-year-olds to enter the workforce and enhance their skills in a highly competitive environment. By the time they are in their late 20s, they are relatively skillful, have been exposed to more than a couple of different jobs or professional settings, and some have cut their teeth in managerial positions as well.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_z4eQUU8KG_pYtvCwEFLnw.jpeg" /></figure><p>This is not really the case with most young people in <strong>Athens</strong>, and it is not for lack of them trying. Studies last longer; there are fewer established companies with solid organizational structures to help them grow well-rounded capabilities; the smaller market means young professionals get less exposure to large, complicated projects. This is clearly not just a Greek problem, but the dragging economy is placing all these talented individuals at the risk of never reaching their potential. Some are fleeing to other countries, making <a href="http://money.cnn.com/2015/06/24/news/economy/greece-europe-brain-drain/">brain drain</a> a national issue. Others, perhaps subconsciously, may lower their expectations and start wondering whether investing in themselves is worthwhile or not.</p><p>Thankfully, there is a more optimistic perspective: compared to London, at least, wages are lower and the potential is there. Young professionals are increasingly eager to learn so that they can actually earn.</p><p>Finding the talent to grow into the next generation of achievers, managers and leaders is a big challenge — but a positive one to face.</p><h3><strong><em>Is there a winner?</em></strong></h3><p>This is not a zero sum game — but it does not take much to pick its winner. As evidenced by the countless startups moving to London from all over the world, the city is a magnet for those embarking on the entrepreneurial journey.</p><p>However, this is not the point.</p><p>One of the main traits of entrepreneurs is to “<a href="http://www.brainyquote.com/quotes/quotes/w/waynegretz383282.html">skate where the puck is going to be, not where it has been</a>”. There is a fundamental challenge there: people always feel much more comfortable with whatever they know has been working well, and struggle when it comes to picking the next winner. (This is, after all, how fortunes are made in the stock market.)</p><p>Thousands of founders are contemplating which “startup ecosystem” to call home. Accelerators, incubators, politicians are all trying to promote their own cities. And we have all read our share of articles evaluating which ecosystems are ideal for specific industries.</p><p>This article is not about promoting any particular city for your startup. It is about looking beyond the ecosystem, and seeking the specific characteristics that make sense for you and your startup.</p><p>Ask yourself:</p><ul><li>Where are our customers, users, partners? How close to them do we need to be, how often, and why?</li><li>What kind of talent do we need, and where should each team member be based? Does the kind of talent we want prefer to work for startups, or is the target city geared to those who prefer 9-to-5, predictable jobs?</li><li>What kind of pivot in our plan would make this city less appealing?</li><li>Could an unexpected local or global event make this city inappropriate for us?</li><li>What other cities share the same key characteristics, but are less “celebrated”?</li><li>What kind of value for money are we looking for, and where does that value come from? (Hopefully it’s not from the free food at startup events).</li></ul><p><strong><em>Postscript: So could the winner be …Athens?</em></strong></p><p>That’s your call, but for all its troubles, Athens still has 2 things going for it…</p><p>One of them is the power of the underdog: The hardships bring the competition for startup resources down and keep the costs modest overall..</p><p>And the other is… the room to build momentum: Athens is barely moving, but if it starts rolling in the right direction, it may work wonders.</p><p>Let’s hope it has cash to buy gas.</p><p><em>Photos by </em><a href="https://www.flickr.com/photos/gareth1953/4505548252"><em>Gareth Williams</em></a><em>, </em><a href="https://www.flickr.com/photos/cebete/8709984884"><em>Andrea Puggioni</em></a><em>, </em><a href="https://www.flickr.com/photos/acme/3733803925"><em>Leon Brocard</em></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=650db553c3e7" width="1" height="1" alt=""><hr><p><a href="https://medium.com/the-startup-magazine-collection/the-unbalanced-startup-scorecard-650db553c3e7">The unbalanced startup scorecard:</a> was originally published in <a href="https://medium.com/the-startup-magazine-collection">Startup Mag</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>